Preimplantation Genetic Testing (PGT) is an in vitro fertilization technology that evaluates the genetic makeup of embryos before transfer, serving as an important component of preventive medicine. Through molecular genetic screening and diagnosis of genetic diseases at the embryonic stage, embryos without disease phenotypes are selected for uterine transfer.
Compared to prenatal diagnosis, the advantage of PGT lies in screening and diagnosing pre-implantation embryos, achieving eugenics from the source of pregnancy. Especially for women with recurrent miscarriages and advanced maternal age, PGT can effectively increase their pregnancy success rate by screening embryos for aneuploidy and structural abnormalities.
As a professional IVF center, AmCan Fertility has its own advanced embryo laboratory and performs genetic screening on embryos to ensure optimal conditions and quality for embryo development. Through PGT, we can assess the health of embryos and screen out potential genetic diseases and abnormalities. This helps in selecting high-quality embryos for transfer, increasing the chances of pregnancy. Our professional laboratory strictly adheres to quality control protocols and safety measures to ensure the accuracy, reliability, and traceability of the procedures. We implement appropriate embryo labeling and tracking measures, strictly record processes and results, and comply with regulatory guidelines to ensure your safety and the reliability of treatment.